Dieter Dorsch,Rolf Gericke,Werner Mederski,Norbert Beier,Florian Lang
申请号：
US11665854
公开号：
US08815924B2
申请日:
2005.04.04
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Novel heterocyclic compounds of the formula (I), in which R1, D, W, T and T′ have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.
